Australia's Avecho Biotech says CBD product design completed, shares jump

Avecho Biotechnology

21/05/2021 06:39

** Shares of Avecho Biotechnology Ltd  AVE.AX  rise as much
as 20% to A$0.018, marking their biggest intraday pct gain since
March 12
    ** Biotech firm says Catalent  CTLT.N , the manufacturer of
its cannabidiol (CBD) soft-gel product, has completed the
composition and design of the dosage form intended for
registration  urn:newsml:reuters.com:*:nASX7J9P8T
    ** Stock hits highest since May 12
    ** More than 9.4 mln shares change hands, vs the 30-day
average volume of ~2.7 mln
    ** Stock down 48.3% YTD, as of last close

 (Reporting by Arundhati Dutta in Bengaluru)
 ((Arundhati.Dutta@thomsonreuters.com;))